REG - Alliance Pharma PLC - Annual Report and AGM Notice <ALAPH.L>
.
For best results when printing this announcement, please click on the link below:
http://pdf.reuters.com/Regnews/regnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20100427:nRSa8459Ka
RNS Number : 8459K
Alliance Pharma PLC
27 April 2010
For immediate release 27 April 2010
27 April 2010
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Annual Report and AGM Notice
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, is pleased to announce that its 2009 Annual
Report
and Notice of the Annual General Meeting, which will be held on 27 May 2010, are now available on the Company's website
at
www.alliancepharma.co.uk.
Printed copies of both documents have been posted to shareholders today and may also be requested by email at
ir@alliancepharma.co.uk.
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk
Buchanan Communications + 44 (0) 20 7466 5000
Mark Court / Stasa Filiplic / Jennie Spivey
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Brent Nabbs
Corporate Broking: David Poutney
Nominated Adviser: Michael Meade / Brent Nabbs
Corporate Broking: David Poutney
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has a strong track record of acquiring the rights to established niche products and, following the Cambridge
Laboratories acquisition, owns or licenses the rights to more than 50 pharmaceutical products and continues to explore
opportunities to expand the range.
Alliance's products are prescribed in the treatment of a wide range of conditions and include products used in the
treatment of dermatological conditions, in oncology, in childbirth, in the prevention of heart disease, in Parkinson's
disease, in nutrition and in nasal infections. Alliance's sales are mainly prescription driven. Its products are
distributed to hospitals directly and to pharmaceutical wholesalers, which service both hospital and retail pharmacies
with
their prescription requirements.
Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
